Torrent Pharmaceuticals Limited (TORNTPHARM) - Total Assets

Latest as of March 2026: Rs443.12 Billion INR ≈ $4.79 Billion USD

Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) holds total assets worth Rs443.12 Billion INR (≈ $4.79 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Torrent Pharmaceuticals Limited - Total Assets Trend (2005–2026)

This chart illustrates how Torrent Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. Also see Torrent Pharmaceuticals Limited market cap and net worth for the company's overall valuation and market capitalisation.

Torrent Pharmaceuticals Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Torrent Pharmaceuticals Limited's total assets of Rs443.12 Billion consist of 21.2% current assets and 78.8% non-current assets. Review TORNTPHARM total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	2.6%
Accounts Receivable	Rs30.36 Billion	6.9%
Inventory	Rs31.38 Billion	7.1%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs244.64 Billion	55.2%
Goodwill	Rs39.90 Billion	9.0%

Asset Composition Trend (2005–2026)

This chart illustrates how Torrent Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See TORNTPHARM live share price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Torrent Pharmaceuticals Limited's current assets represent 21.2% of total assets in 2026, a decrease from 37.3% in 2005.
Cash Position: Cash and equivalents constituted 2.6% of total assets in 2026, up from 1.5% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 64.0% of total assets, an increase from 13.0% in 2005.
Asset Diversification: The largest asset category is intangible assets at 55.2% of total assets.

Torrent Pharmaceuticals Limited Competitors by Total Assets

Key competitors of Torrent Pharmaceuticals Limited based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥31.82 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	China	CN¥17.01 Billion

Torrent Pharmaceuticals Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.13	1.19	1.13
Quick Ratio	0.75	0.65	0.58
Cash Ratio	0.00	0.12	0.00
Working Capital	Rs10.49 Billion	Rs9.06 Billion	Rs6.30 Billion

Torrent Pharmaceuticals Limited - Advanced Valuation Insights

This section examines the relationship between Torrent Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	22.33
Latest Market Cap to Assets Ratio	0.05
Asset Growth Rate (YoY)	195.6%
Total Assets	Rs443.12 Billion
Market Capitalization	$19.95 Billion USD

Valuation Analysis

Below Book Valuation: The market values Torrent Pharmaceuticals Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Torrent Pharmaceuticals Limited's assets grew by 195.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Torrent Pharmaceuticals Limited (2005–2026)

The table below shows the annual total assets of Torrent Pharmaceuticals Limited from 2005 to 2026.

Year	Total Assets	Change
2026-03-31	Rs443.12 Billion ≈ $4.79 Billion	+195.61%
2025-03-31	Rs149.90 Billion ≈ $1.62 Billion	-0.47%
2024-03-31	Rs150.61 Billion ≈ $1.63 Billion	+0.32%
2023-03-31	Rs150.12 Billion ≈ $1.62 Billion	+14.60%
2022-03-31	Rs131.00 Billion ≈ $1.42 Billion	-6.93%
2021-03-31	Rs140.75 Billion ≈ $1.52 Billion	+0.26%
2020-03-31	Rs140.38 Billion ≈ $1.52 Billion	-0.59%
2019-03-31	Rs141.21 Billion ≈ $1.53 Billion	-0.86%
2018-03-31	Rs142.43 Billion ≈ $1.54 Billion	+40.67%
2017-03-31	Rs101.25 Billion ≈ $1.09 Billion	+12.33%
2016-03-31	Rs90.14 Billion ≈ $974.79 Million	+13.94%
2015-03-31	Rs79.11 Billion ≈ $855.55 Million	+56.04%
2014-03-31	Rs50.70 Billion ≈ $548.28 Million	+34.02%
2013-03-31	Rs37.83 Billion ≈ $409.10 Million	+23.08%
2012-03-31	Rs30.74 Billion ≈ $332.39 Million	+20.61%
2011-03-31	Rs25.48 Billion ≈ $275.60 Million	+29.68%
2010-03-31	Rs19.65 Billion ≈ $212.52 Million	+17.85%
2009-03-31	Rs16.67 Billion ≈ $180.33 Million	+31.73%
2008-03-31	Rs12.66 Billion ≈ $136.90 Million	+21.14%
2007-03-31	Rs10.45 Billion ≈ $113.01 Million	+10.94%
2006-03-31	Rs9.42 Billion ≈ $101.86 Million	+32.54%
2005-03-31	Rs7.11 Billion ≈ $76.85 Million	--

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$19.95 Billion

Rs1.84 Trillion INR

Market Cap Rank

#1284 Global

#37 in India

Share Price

Rs4850.00

Change (1 day)

-2.33%

52-Week Range

Rs3514.70 - Rs5122.80

All Time High

Rs5122.80